Research by Lancaster University scientists to create a COVID-19 vaccine which can be administered through the nose has taken a significant step forward.
The partnership will see Quanticate support research into optimizing clinical trial design for rare disease and the role of response-adaptive randomisation. STOR-i was established in 2010 as an Engineering and Physical Sciences Resaearch Council EPSRC Cen